Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Robert O. Bash"'
Autor:
Arlynn F. Mulne, Gail E. Tomlinson, Victor M. Aquino, Daniel C. Bowers, Naomi J. Winick, Heidi J. Haynes, Janna M. Journeycake, Robert O. Bash, Patrick J. Leavey
Publikováno v:
Pediatric Blood & Cancer. 42:93-98
Background. To determine the maximumtolerated duration and dose-limiting toxicity of a daily schedule of orally administered cyclophosphamide and topotecan in pediatric patients with recurrent or refractory malignant solid tumors. Methods. Patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee0e20fdec11611a671aa6c9b20d8b4
https://doi.org/10.1002/pbc.10456
https://doi.org/10.1002/pbc.10456
Autor:
Eleonora Hansch, Raymond Quigley, Gerald S. Arbus, Jeffrey M. Saland, Patrick J. Leavey, Robert O. Bash
Publikováno v:
Pediatric Nephrology. 17:825-829
The purpose of the present study was to examine the clearance of methotrexate (MTX) by high-flux hemodialysis (HD) in pediatric oncology patients. We present three patients who experienced nephrotoxicity and prolonged exposure to toxic MTX concentrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ecc98fd27e959e831c3b8c9208443c
https://doi.org/10.1007/s00467-002-0946-7
https://doi.org/10.1007/s00467-002-0946-7
Publikováno v:
Leukemia. 14:1215-1224
The identification of prognostic parameters and surrogate markers for defining patient risk has been beneficial in effectively guiding therapy and increasing the survival of leukemia patients. It has been hypothesized that the therapeutic response, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e35835215ff64ae3ac3315ee2a5ced8
https://doi.org/10.1038/sj.leu.2401814
https://doi.org/10.1038/sj.leu.2401814
Autor:
Mary V. Relling, Robert O. Bash, Susana C. Raimondi, Naomi J. Winick, Michael D. Amylon, Barton A. Kamen, Bruce M. Camitta, C. Chen, Jonathan J. Shuster, Michael H. Woo, Carolyn A. Felix, Frederick G. Behm, Ching-Hon Pui
Publikováno v:
Leukemia. 14:232-237
Epipodophyllotoxin-associated secondary myeloid leukemia is a devastating complication of acute lymphoblastic leukemia (ALL) therapy. The risk factors for treatment-related myeloid leukemia remain incompletely defined. Genetic deficiencies in glutath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::087b8b18b8ccdf5413dad134de0e4dd5
https://doi.org/10.1038/sj.leu.2401660
https://doi.org/10.1038/sj.leu.2401660
Publikováno v:
The American Journal of Pathology. 154:1023-1035
The presence of occult disease in cancer patients after therapy is one of the major problems faced by oncologists. For example, although 95% of pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients have a complete therapeutic response to mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6015386ebbac059dfcafcef7646e5c81
https://doi.org/10.1016/s0002-9440(10)65355-2
https://doi.org/10.1016/s0002-9440(10)65355-2
Autor:
William M. Crist, RG Smith, Robert O. Bash, S Hall, Richard Baer, Michael D. Amylon, Charles F. Timmons
Publikováno v:
Blood. 86:666-676
Almost 25% of patients with T-cell acute lymphoblastic leukemia (T-ALL) have tumor-specific rearrangements of the TAL1 gene. Although TAL1 expression has not been observed in normal lymphocytes, TAL1 gene products are readily detected in leukemic cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f58d69f442839e82b20ee807f07fb9cc
https://doi.org/10.1182/blood.v86.2.666.bloodjournal862666
https://doi.org/10.1182/blood.v86.2.666.bloodjournal862666
Publikováno v:
Cancer. 74:189-196
Background. Standard treatment for fever during periods of chemotherapy-induced neutropenia includes hospitalization and administration of intravenous antibiotics until the patient is afebrile and no longer neutropenic. This study prospectively evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de8f95982ec87b16c3712777e671060b
https://doi.org/10.1002/1097-0142(19940701)74:1<189::aid-cncr2820740130>3.0.co
https://doi.org/10.1002/1097-0142(19940701)74:1<189::aid-cncr2820740130>3.0.co
Publikováno v:
Clinical Immunology Newsletter. 14:33-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f61423229ef33c8f1fd6cf229718ebf
https://doi.org/10.1016/0197-1859(94)90028-0
https://doi.org/10.1016/0197-1859(94)90028-0
Autor:
J Pullen, AJ Carroll, Jonathan J. Shuster, Michael D. Amylon, William M. Crist, Robert O. Bash, Michael P. Link, Richard Baer, George R. Buchanan, RG Smith
Publikováno v:
Blood. 81:2110-2117
Alteration of the TAL1 locus is the most common nonrandom genetic defect in childhood T-cell acute lymphoblastic leukemia (T-ALL). To determine if rearrangements of the TAL1 proto-oncogene confer a distinct leukemic phenotype, we studied leukemic per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94895a1acd30ef8ec826c50a95031ca6
https://doi.org/10.1182/blood.v81.8.2110.bloodjournal8182110
https://doi.org/10.1182/blood.v81.8.2110.bloodjournal8182110
Publikováno v:
Cancer. 68:940-943
A routine admission chest radiograph (CXR) in pediatric patients with cancer who are admitted to the hospital for fever and neutropenia has been advised because the signs and symptoms of pneumonia may be absent. The authors studied 131 consecutive pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::459aead1b1f71505cd1529a35ad6040a
https://doi.org/10.1002/1097-0142(19910901)68:5<940::aid-cncr2820680505>3.0.co
https://doi.org/10.1002/1097-0142(19910901)68:5<940::aid-cncr2820680505>3.0.co